Publications by authors named "Laurie Warren"

Nitrate is one of the most commonly detected contaminants found in aquatic systems with other pesticides such as atrazine. The current study examined potential combined effects of nitrate and atrazine on adults of the freshwater amphipod Hyalella azteca, using survival and precopulatory guarding behavior as toxic endpoints. Although significant differences in acute toxicity with nitrate alone and in binary combination with atrazine (200 µg/L) in water-only tests were not consistently observed for each time point, potential biologically relevant trends in the data were observed.

View Article and Find Full Text PDF

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is predominantly expressed in liver and regulates cholesterol metabolism by down regulating liver LDL receptor (LDLR) proteins. Here we report transgenic overexpression of human PCSK9 in kidney increased plasma levels of PCSK9 and subsequently led to a dramatic reduction in liver LDLR proteins. The regulation of LDLR by PCSK9 displayed tissue specificity, with liver being the most responsive tissue.

View Article and Find Full Text PDF

Sterol regulatory element-binding proteins (SREBPs) are major transcriptional regulators of cholesterol, fatty acid, and glucose metabolism. Genetic disruption of SREBP activity reduces plasma and liver levels of cholesterol and triglycerides and insulin-stimulated lipogenesis, suggesting that SREBP is a viable target for pharmacological intervention. The proprotein convertase SREBP site 1 protease (S1P) is an important posttranscriptional regulator of SREBP activation.

View Article and Find Full Text PDF

The discovery and efficacy of a series of potent aminopyrrolidineamide-based inhibitors of sterol regulatory element binding protein site-1 protease is described.

View Article and Find Full Text PDF

Proprotein convertase subtilisin kexin type 9 (PCSK9) lowers the abundance of surface low-density lipoprotein (LDL) receptor through an undefined mechanism. The structure of human PCSK9 shows the subtilisin-like catalytic site blocked by the prodomain in a noncovalent complex and inaccessible to exogenous ligands, and that the C-terminal domain has a novel fold. Biosensor studies show that PCSK9 binds the extracellular domain of LDL receptor with K(d) = 170 nM at the neutral pH of plasma, but with a K(d) as low as 1 nM at the acidic pH of endosomes.

View Article and Find Full Text PDF